Artificial Shrinkage for Human Blastocyst Prior Vitrification
- Conditions
- Vitrification
- Interventions
- Procedure: Artificial shrinkage
- Registration Number
- NCT02976662
- Lead Sponsor
- Dar AlMaraa Center
- Brief Summary
Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.
- Detailed Description
Human blastocyst formation begins about 5 days after injecting a single sperm into an oocyte in ICSI cycle or incubation of them in IVF cycle. Human blastocyst consists of cells forming an outer layer called trophotoderm that will form the placenta in case of successful implantation, an inner cell mass which become the fetus, a fluid-filled blastocoel cavity in the center, and a surrounding zone pellucida from which the embryo hatches to implant in the uterus. Human blastocyst contains a large amount of liquid in the blastocoel, which alters the infiltration of vitrification solution during the vitrification procedures leading to ice crystal formation. Therefore, investigators need to compare blastocyst survival, clinical pregnancy and implantation rates between vitrified untreated expanded blastocysts and vitrified blastocysts with artificially eliminated blastocoels by a laser pulse prior to vitrification
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
- BMI of ≤ 32
- Non-expanded blastocysts.
- Women who had uterine pathology or abnormality.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Artificial shrinkage Artificial shrinkage Elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.
- Primary Outcome Measures
Name Time Method Implantation rate 1 month number of intrauterine gestational sacs over the total number of embryos transferred
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yasmin Magdi
🇪🇬Benha, Egypt